학술논문

Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis
Document Type
article
Source
Arthritis Research & Therapy, Vol 19, Iss 1, Pp 1-7 (2017)
Subject
Palindromic rheumatism
Rheumatoid arthritis
Anticitrullinated peptide/protein antibodies
Vimentin
Diseases of the musculoskeletal system
RC925-935
Language
English
ISSN
1478-6362
Abstract
Abstract Background To analyze differences in the recognition of anti-citrullinated peptide/protein antibody (ACPA) citrullinated epitopes and isotypes in patients with palindromic rheumatism (PR) and rheumatoid arthritis (RA). Methods ACPA fine specificities (citrullinated peptides of enolase, fibrin, and vimentin) and isotypes (IgG, IgM, and IgA) were analyzed in 54 patients with longstanding PR and 54 patients with established RA. Results CCP2 tested positive in 66.7% of patients with PR and RA. The ACPA distribution of fine specificities and isotypes differed between PR and RA patients. PR patients had a lower frequency of fine ACPA specificities than RA patients, which was significant in the case of a peptide derived from vimentin (PR 24.1% vs. 59.3% RA; p